A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

The latest round of terminations, which will take effect Sept. 15, comes after Genentech fired more than 500 employees in the ...

Haleon Pakistan has announced a fresh investment of $12 million to expand its manufacturing capacity, focusing on scaling up ...

Just when the future looked bleak for GSK’s Blenrep comeback in the U.S., the FDA has blessed the company's multiple myeloma ...

The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...

The melanoma market is predicted to surge during the forecast period (2025–2034) owing to factors, as the increasing incidence of melanoma, the launc ...

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and ...

Market OutlineThe Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to ...

Kurt Sievers, the CEO of Dutch semiconductor giant NXP Semiconductors, who is set to officially step down at the end of October 2025, recently visited Shanghai and met with the mayor of Shanghai ...

GSK supports seasonal flu immunization in the US by shipping FLULAVAL (Influenza Vaccine) and FLUARIX (Influenza Vaccine) in advance of flu season PHILADELPHIA-- (BUSINESS WIRE)--GSK plc (LSE/NYSE: ...

(RTTNews) - GSK plc (GSK, GSK.L) announced Thursday it has started shipping doses of its trivalent seasonal influenza vaccines to US healthcare providers and pharmacies in preparation for the 2025 ...